MXPA03004638A - Adyuvantes de acido nucleico. - Google Patents

Adyuvantes de acido nucleico.

Info

Publication number
MXPA03004638A
MXPA03004638A MXPA03004638A MXPA03004638A MXPA03004638A MX PA03004638 A MXPA03004638 A MX PA03004638A MX PA03004638 A MXPA03004638 A MX PA03004638A MX PA03004638 A MXPA03004638 A MX PA03004638A MX PA03004638 A MXPA03004638 A MX PA03004638A
Authority
MX
Mexico
Prior art keywords
nucleic acid
molecules
truncated
acid adjuvants
coding region
Prior art date
Application number
MXPA03004638A
Other languages
English (en)
Spanish (es)
Inventor
Joel R Haynes
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of MXPA03004638A publication Critical patent/MXPA03004638A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03004638A 2000-11-27 2001-11-26 Adyuvantes de acido nucleico. MXPA03004638A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72431500A 2000-11-27 2000-11-27
PCT/US2001/043151 WO2003004055A2 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Publications (1)

Publication Number Publication Date
MXPA03004638A true MXPA03004638A (es) 2004-04-20

Family

ID=24909936

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004638A MXPA03004638A (es) 2000-11-27 2001-11-26 Adyuvantes de acido nucleico.

Country Status (16)

Country Link
EP (1) EP1379273B1 (cg-RX-API-DMAC7.html)
JP (1) JP4221289B2 (cg-RX-API-DMAC7.html)
KR (1) KR20040045391A (cg-RX-API-DMAC7.html)
CN (1) CN1317034C (cg-RX-API-DMAC7.html)
AT (1) ATE442858T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001297988B2 (cg-RX-API-DMAC7.html)
BR (1) BR0115646A (cg-RX-API-DMAC7.html)
CA (1) CA2429708A1 (cg-RX-API-DMAC7.html)
DE (1) DE60139959D1 (cg-RX-API-DMAC7.html)
DK (1) DK1379273T3 (cg-RX-API-DMAC7.html)
ES (1) ES2332261T3 (cg-RX-API-DMAC7.html)
IL (2) IL156041A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03004638A (cg-RX-API-DMAC7.html)
NZ (1) NZ526175A (cg-RX-API-DMAC7.html)
PT (1) PT1379273E (cg-RX-API-DMAC7.html)
WO (1) WO2003004055A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035771A2 (en) 2003-10-10 2005-04-21 Powderject Vaccines, Inc. Nucleic acid constructs
ATE555127T1 (de) 2004-02-11 2012-05-15 Angeletti P Ist Richerche Bio Fusionsproteine des karzinomembryonalen antigens und deren verwendungen
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
US8389686B2 (en) 2008-05-07 2013-03-05 Osaka University Noncovalent collagen crosslinking agent
AU2011302645B2 (en) 2010-09-15 2015-02-26 Applied Molecular Transport, Llc Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CN103060253A (zh) * 2013-01-24 2013-04-24 麻丽丹 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用
EP3139965B1 (en) 2014-05-07 2021-09-29 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
PL3762009T3 (pl) 2018-03-08 2022-09-12 Applied Molecular Transport Inc. Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego
ES2911075T3 (es) 2018-11-07 2022-05-17 Applied Molecular Transport Inc Constructos de administración para transcitosis y métodos relacionados
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
DE69507321T2 (de) 1994-10-24 1999-07-15 Powderject Research Ltd., Oxford Nadellose spritze
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
AU2001297988B2 (en) 2006-10-26
CN1537013A (zh) 2004-10-13
JP4221289B2 (ja) 2009-02-12
ES2332261T3 (es) 2010-02-01
EP1379273A2 (en) 2004-01-14
WO2003004055A2 (en) 2003-01-16
IL156041A0 (en) 2003-12-23
JP2004536107A (ja) 2004-12-02
PT1379273E (pt) 2009-11-27
NZ526175A (en) 2006-01-27
CN1317034C (zh) 2007-05-23
CA2429708A1 (en) 2003-01-16
IL156041A (en) 2010-05-17
WO2003004055A3 (en) 2003-11-20
DK1379273T3 (da) 2009-11-09
ATE442858T1 (de) 2009-10-15
DE60139959D1 (de) 2009-10-29
KR20040045391A (ko) 2004-06-01
EP1379273B1 (en) 2009-09-16
BR0115646A (pt) 2005-12-13

Similar Documents

Publication Publication Date Title
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
CY1110982T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
GB2347932B (en) Vectors for the delivery of 5T4 antigen
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
BR9906927A (pt) Proteìnas de neisseria meningitidis
MXPA01003557A (es) Secuencias genomicas de neisseria y metodos para su uso.
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
WO2001035991A3 (en) Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
EP1288299A3 (en) TRNA synthetase
AU7235794A (en) Vaccine compositions
NZ532665A (en) Neisseria meningitidis antigens and compositions
IL156041A0 (en) Nucleic acid adjuvants
WO2003085085A3 (en) Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
WO2002062296A3 (en) Methods and compositions useful for stimulating an immune response
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
DK1379550T3 (da) Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser
ATE392216T1 (de) Mycobakterieller impfstoff
AU2001248822A1 (en) Gd3-mimetic peptides
MXPA01008605A (es) Proteina de enlace del antigeno goodpasture.
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
WO2000063385A3 (en) Nucleic acid immunization
WO2000052045A3 (en) Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof

Legal Events

Date Code Title Description
FG Grant or registration